Sequenom (SQNM): Bullish on the technology and Sequenom's prospects for commercializing T-21 in 2011 - Barclays
Tweet Send to a Friend
From Notable Calls:
Barclays Capital is out surprisingly positive on Sequenom (NASDAQ: SQNM) ahead of of forthcoming data on sequencing for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Barclays Capital is out surprisingly positive on Sequenom (NASDAQ: SQNM) ahead of of forthcoming data on sequencing for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
